222 related articles for article (PubMed ID: 18998071)
21. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
[TBL] [Abstract][Full Text] [Related]
22. Hepatic osteodystrophy: a review.
Idilman R; de Maria N; Uzunalimoglu O; van Thiel DH
Hepatogastroenterology; 1997; 44(14):574-81. PubMed ID: 9164540
[TBL] [Abstract][Full Text] [Related]
23. Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis.
Argao EA; Balistreri WF; Hollis BW; Ryckman FC; Heubi JE
Hepatology; 1994 Sep; 20(3):598-603. PubMed ID: 8076918
[TBL] [Abstract][Full Text] [Related]
24. Extrahepatic manifestations of cholestasis.
Glasova H; Beuers U
J Gastroenterol Hepatol; 2002 Sep; 17(9):938-48. PubMed ID: 12167113
[TBL] [Abstract][Full Text] [Related]
25. Hepatic osteodystrophy in cirrhosis due to alcohol-related liver disease.
Pereira F; Azevedo R; Linhares M; Pinto J; Leitão C; Caldeira A; Tristan J; Pereira E; Sousa R; Banhudo A
Rev Esp Enferm Dig; 2021 Aug; 113(8):563-569. PubMed ID: 33267594
[TBL] [Abstract][Full Text] [Related]
26. Bone health and disease in cystic fibrosis.
Marquette M; Haworth CS
Paediatr Respir Rev; 2016 Aug; 20 Suppl():2-5. PubMed ID: 27461283
[TBL] [Abstract][Full Text] [Related]
27. [Osteoporosis].
Ziegler R
Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1051-5. PubMed ID: 7939067
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density deficiency in children.
Tortolani PJ; McCarthy EF; Sponseller PD
J Am Acad Orthop Surg; 2002; 10(1):57-66. PubMed ID: 11809051
[TBL] [Abstract][Full Text] [Related]
29. Alcoholic liver disease and changes in bone mineral density.
López-Larramona G; Lucendo AJ; González-Delgado L
Rev Esp Enferm Dig; 2013; 105(10):609-21. PubMed ID: 24641458
[TBL] [Abstract][Full Text] [Related]
30. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.
Dibble JB; Sheridan P; Hampshire R; Hardy GJ; Losowsky MS
Q J Med; 1982; 51(201):89-103. PubMed ID: 6981120
[TBL] [Abstract][Full Text] [Related]
31. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
Moschen AR; Kaser A; Stadlmann S; Millonig G; Kaser S; Mühllechner P; Habior A; Graziadei I; Vogel W; Tilg H
J Hepatol; 2005 Dec; 43(6):973-83. PubMed ID: 16143421
[TBL] [Abstract][Full Text] [Related]
32. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
Monegal A; Navasa M; Peris P; Alvarez L; Pons F; Rodés J; Guañabens N
Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
[TBL] [Abstract][Full Text] [Related]
33. Liver disease and osteoporosis.
Sanchez AJ; Aranda-Michel J
Nutr Clin Pract; 2006 Jun; 21(3):273-8. PubMed ID: 16772544
[TBL] [Abstract][Full Text] [Related]
34. [Osteoporosis in the aged male].
Szulc P; Delmas PD
Presse Med; 2002 Nov; 31(37 Pt 1):1760-9. PubMed ID: 12489321
[TBL] [Abstract][Full Text] [Related]
35. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development.
Ehnert S; Aspera-Werz RH; Ruoß M; Dooley S; Hengstler JG; Nadalin S; Relja B; Badke A; Nussler AK
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137669
[TBL] [Abstract][Full Text] [Related]
36. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
Trautwein C; Possienke M; Schlitt HJ; Böker KH; Horn R; Raab R; Manns MP; Brabant G
Am J Gastroenterol; 2000 Sep; 95(9):2343-51. PubMed ID: 11007240
[TBL] [Abstract][Full Text] [Related]
37. Alteration of bone mineral density in cystic fibrosis adults.
Neri AS; Lori I; Taccetti G; Festini F; de Martino M; Masi L; Brandi ML
Chest; 2006 Dec; 130(6):1952-3; author reply 1953. PubMed ID: 17167027
[No Abstract] [Full Text] [Related]
38. Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.
Yurci A; Kalkan AO; Ozbakir O; Karaman A; Torun E; Kula M; Baskol M; Gursoy S; Yucesoy M; Bayram F
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1206-12. PubMed ID: 21971374
[TBL] [Abstract][Full Text] [Related]
39. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density before and after OLT: long-term follow-up and predictive factors.
Guichelaar MM; Kendall R; Malinchoc M; Hay JE
Liver Transpl; 2006 Sep; 12(9):1390-402. PubMed ID: 16933236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
